These Unapproved Drugs Were Affected by the FDA's Latest Seizure

Over $11 million worth of unapproved drugs have been seized by the U.S. marshals per request of the FDA and the U.S. Attorney for the Southern District of Ohio.

The unapproved drugs were marketed by Ascend Laboratories of Montvale, NJ, and distributed by Masters Pharmaceuticals of Cincinnati, OH. The FDA alleged that the products were unapproved and misbranded after a November 2013 inspection at Ascend Laboratories that revealed the marketing of these products without an FDA-approved drug application.